Initiation Reports

Basic Materials

Synnovia - FY results, encouraging signs

Synnovia (LON:SYN) has released its full-year (FY) results to March...

on 9/7/19

GRIT Real Estate - The next level

GRIT Real Estate Income Group (LON:GR1T), the leading pan-African...

on 27/6/19

MTI Wireless Edge - Expanding irrigation opportunity

MTI Wireless Edge (LON:MWE) recently announced the acquisition of a...

on 27/6/19
Basic Materials

Itaconix PLC- Transformation bearing results

Itaconix's (LON:ITX) results for the year to December 2019 were in...

on 27/6/19

Analyst interviews

Broad label approval is 'best possible outcome' for Shield Therapeutics'...

Proactive Research analyst Emma Ulker discusses what she describes as the best possible outcome for its lead drug Feraccru.  The US Food & Drug Administration (FDA) has approved the treatment for a broad label to treat iron deficiency (ID) in adults, addressing a population many...

2 weeks, 3 days ago